Gibson, Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Rose advised Sixth Street. Arrowhead...
Arrowhead Pharmaceuticals’ Financing Agreement with Sixth Street
Apellis Pharmaceuticals’ $475 Million Financing Agreement with Sixth Street
Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals, Inc. on the deal, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Eose advised Sixth...
Daré Bioscience’s $22 Million Non-Dilutive Strategic Royalty Financing
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Daré Bioscience, Inc. on the transaction, and Gibson, Dunn & Crutcher advised XOMA (US) LLC. Daré Bioscience, Inc....
Immusoft’s Research Collaboration and Licensing Agreement With Takeda
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Immusoft on the deal. Immusoft, a cell therapy company dedicated to improving the lives of patients with rare...